-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Yimaitong compiles and arranges, please do not reprint
without authorization.
Introduction: About
New modelling data show that the number of people with type 1 diabetes worldwide is expected to double by 2040, and most new cases will occur in adults in low- and middle-income countries, the study was published in The lancet Diabetes & endocrinology, MD Chantal Mathieu, MD, said at the European Association for the Study of
The results of the study emphasize the need for
early diagnosis of type 1 diabetes and timely high-quality diagnosis and care for patients.
”
Type 1 diabetes deaths: 1 in 5 occur under 25 years of age
Research shows that about 8.
4 million people worldwide had type 1 diabetes in 2021, with one in five coming from low- and middle-income countries
.
It is estimated that one in five deaths from type 1 diabetes in 2021 occurred in people under the age of 25, mainly due to undiagnosed and untreated
conditions.
The model predicts that by 2040, the number of people with type 1 diabetes will reach 13.
50~17.
4 million, with the largest
relative increase in low- and lower-middle-income countries.
The majority of onset and epidemic cases of type 1 diabetes occur in adults, with an estimated 62% of the 510,000 new diagnoses worldwide in 2021 occurring in
people aged 20 years and older.
"In 2022, it is unacceptable
that approximately 35,000 people worldwide will die without being diagnosed within a year of symptom onset.
There are still huge disparities in life expectancy among people with type 1 diabetes, with people in the poorest countries affecting people the most," said
Mathieu, senior vice president at EASD and an endocrinologist at the University of Leuven in Belgium.
People with type 1 diabetes: You can't just focus on children
Mathieu pointed out that the long-held perception that type 1 diabetes is mainly a pediatric disease is not accurate
.
In fact, worldwide, the average age of people with type 1 diabetes is 37 years
.
While type 1 diabetes is often referred to as "
.
Children grow up, adults get older, and all countries must step up the diagnosis and care of people with type 1 diabetes of all ages
.
Urgent need for improvement: diagnosis and monitoring of type 1 diabetes
Researchers say the prevalence of type 1 diabetes is high worldwide, and the numbers are growing
.
Improved diagnosis and surveillance are essential to change clinical outcomes, especially in adults
who make up the majority of people with type 1 diabetes.
In the coming decades, we have the opportunity to save millions of lives
by improving the standard of care, including ensuring access to insulin and other essential supplies, and raising awareness of the signs and symptoms of type 1 diabetes, leading to 100% diagnostic rates in all countries.
Resources:
[1] Gregory GA, Robinson T, Linklater SE, et al.
Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study[J].
The lancet Diabetes & endocrinology.
2022 Oct,10（10）: 741-760.
DOI: 10.
1016/S2213-8587（22）00218-2, PMID:36113507
[2] Miriam E.
Tucker.
Type 1 Diabetes Cases Poised to Double Worldwide by 2040[EB/OL].
[2022-9-22].
#vp_1.
